Mark K. Bakker

2.6k total citations
11 papers, 176 citations indexed

About

Mark K. Bakker is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Mark K. Bakker has authored 11 papers receiving a total of 176 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Mark K. Bakker's work include Intracranial Aneurysms: Treatment and Complications (6 papers), Moyamoya disease diagnosis and treatment (4 papers) and Genetic Associations and Epidemiology (4 papers). Mark K. Bakker is often cited by papers focused on Intracranial Aneurysms: Treatment and Complications (6 papers), Moyamoya disease diagnosis and treatment (4 papers) and Genetic Associations and Epidemiology (4 papers). Mark K. Bakker collaborates with scholars based in Netherlands, United Kingdom and United States. Mark K. Bakker's co-authors include Ynte M. Ruigrok, Susanna C. Larsson, Dipender Gill, Ville Karhunen, Guillaume Paré, Chris H. L. Thio, Marlien W. Aalbers, Harold Snieder, Michael Chong and J. Marc C. van Dijk and has published in prestigious journals such as Stroke, European Journal of Neurology and Journal of Psychopharmacology.

In The Last Decade

Mark K. Bakker

9 papers receiving 174 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark K. Bakker Netherlands	6	103	45	40	38	34	11	176
Varinder S. Alg United Kingdom	8	194 1.9×	55 1.2×	76 1.9×	31 0.8×	23 0.7×	11	247
Juhana Frösen Finland	6	263 2.6×	111 2.5×	117 2.9×	37 1.0×	42 1.2×	7	337
Naina L. Gross United States	7	46 0.4×	47 1.0×	26 0.7×	13 0.3×	19 0.6×	17	163
Danny Morrison United Kingdom	9	36 0.3×	26 0.6×	31 0.8×	30 0.8×	27 0.8×	13	184
Anna Hurst United States	9	24 0.2×	21 0.5×	21 0.5×	69 1.8×	56 1.6×	30	175
Kampei Shimizu Japan	12	280 2.7×	122 2.7×	52 1.3×	10 0.3×	37 1.1×	42	357
Elodie Persyn United Kingdom	7	45 0.4×	20 0.4×	16 0.4×	96 2.5×	71 2.1×	7	244
Alessia Giossi Italy	9	116 1.1×	43 1.0×	21 0.5×	24 0.6×	55 1.6×	13	244
Delphine Héron France	8	32 0.3×	20 0.4×	50 1.3×	74 1.9×	90 2.6×	15	214
Yoshio Tokuda Japan	9	333 3.2×	52 1.2×	23 0.6×	23 0.6×	52 1.5×	16	454

Countries citing papers authored by Mark K. Bakker

Since Specialization

Citations

This map shows the geographic impact of Mark K. Bakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark K. Bakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark K. Bakker more than expected).

Fields of papers citing papers by Mark K. Bakker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark K. Bakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark K. Bakker. The network helps show where Mark K. Bakker may publish in the future.

Co-authorship network of co-authors of Mark K. Bakker

This figure shows the co-authorship network connecting the top 25 collaborators of Mark K. Bakker. A scholar is included among the top collaborators of Mark K. Bakker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark K. Bakker. Mark K. Bakker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Wolters, B., Mark K. Bakker, Kristiina Rannikmäe, Paul J. Hop, & Ynte M. Ruigrok. (2025). Rare genetic variants in PKD1 and SMAD2 are associated with intracranial aneurysms in the general population. International Journal of Stroke. 20(8). 1011–1020.

Ruigrok, Ynte M., Jan H. Veldink, & Mark K. Bakker. (2024). Drug classes affecting intracranial aneurysm risk: Genetic correlation and Mendelian randomization. European Stroke Journal. 9(3). 687–695.

Tschiderer, Lena, Mark K. Bakker, Dipender Gill, et al.. (2024). Sex differences in risk factor relationships with subarachnoid haemorrhage and intracranial aneurysms: A Mendelian randomization study. European Stroke Journal. 10(1). 216–224. 1 indexed citations

Bakker, Mark K., et al.. (2022). Genome-wide linkage analysis combined with genome sequencing in large families with intracranial aneurysms. European Journal of Human Genetics. 30(7). 833–840. 5 indexed citations

Bakker, Mark K., et al.. (2022). Anti-Epileptic Drug Target Perturbation and Intracranial Aneurysm Risk: Mendelian Randomization and Colocalization Study. Stroke. 54(1). 208–216. 20 indexed citations

Gaastra, Ben, Mark K. Bakker, Isabel C. Hostettler, et al.. (2022). Genetic variation inNFE2L2is associated with outcome following aneurysmal subarachnoid haemorrhage. European Journal of Neurology. 30(1). 116–124. 4 indexed citations

Thio, Chris H. L., Marlien W. Aalbers, Maarten Uyttenboogaart, et al.. (2022). Sex Hormones and Risk of Aneurysmal Subarachnoid Hemorrhage: A Mendelian Randomization Study. Stroke. 53(9). 2870–2875. 32 indexed citations

Karhunen, Ville, Mark K. Bakker, Ynte M. Ruigrok, Dipender Gill, & Susanna C. Larsson. (2021). Modifiable risk factors for intracranial aneurysm and aneurysmal subarachnoid hemorrhage:a Mendelian randomization study. University of Oulu Repository (University of Oulu). 62 indexed citations

Bakker, Mark K. & Ynte M. Ruigrok. (2021). Genetics of Intracranial Aneurysms. Stroke. 52(9). 3004–3012. 40 indexed citations

10.

Jamain, Stéphane, Dick Schijven, Bochao Lin, et al.. (2020). A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort). Journal of Psychopharmacology. 34(5). 524–531. 9 indexed citations

11.

Kleinloog, Rachel, et al.. (2019). Assessment of the Most Optimal Control Tissue for Intracranial Aneurysm Gene Expression Studies. Stroke. 50(10). 2933–2936. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact